Paper38201655
Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.
Li X and 10 others. Cancers (Basel), 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas. Papers, record 38201655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38201655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JingYiYan 2018-7 | Beijing Municipal Special Funds for Medical Research | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32098194 | Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32098194 | PubMed |
| 2 | 32464096 | The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma. | Cell Stem Cell | 2020 | https://conductscience.org/library/papers/32464096 | PubMed |
| 3 | 35570396 | Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors. | Mol Ther | 2022 | https://conductscience.org/library/papers/35570396 | PubMed |
| 4 | 27157264 | Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. | Curr Neuropharmacol | 2017 | https://conductscience.org/library/papers/27157264 | PubMed |
| 5 | 23512689 | Brainstem glioma: a review. | Curr Neurol Neurosci Rep | 2013 | https://conductscience.org/library/papers/23512689 | PubMed |
| 6 | 20400066 | Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells. | Cell Immunol | 2010 | https://conductscience.org/library/papers/20400066 | PubMed |
| 7 | 17172420 | Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. | Mol Cancer Ther | 2006 | https://conductscience.org/library/papers/17172420 | PubMed |
| 8 | 15870068 | Characterization of the interaction between interleukin-13 and interleukin-13 receptors. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15870068 | PubMed |
| 9 | 22424217 | Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. | Cytotherapy | 2012 | https://conductscience.org/library/papers/22424217 | PubMed |
| 10 | 18590440 | Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen. | J Neurosurg | 2008 | https://conductscience.org/library/papers/18590440 | PubMed |
| 11 | 19276162 | Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. | Mol Cancer Ther | 2009 | https://conductscience.org/library/papers/19276162 | PubMed |
| 12 | 28029927 | Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/28029927 | PubMed |
| 13 | 29203539 | Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. | J Exp Med | 2018 | https://conductscience.org/library/papers/29203539 | PubMed |
| 14 | 37999129 | Surgical Management of Adult Brainstem Gliomas: A Systematic Review and Meta-Analysis. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37999129 | PubMed |
| 15 | 18566228 | Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/18566228 | PubMed |
| 16 | 21030678 | Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/21030678 | PubMed |
| 17 | 16314943 | Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13. | J Neurooncol | 2006 | https://conductscience.org/library/papers/16314943 | PubMed |
| 18 | 21946118 | An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts. | Neuro Oncol | 2012 | https://conductscience.org/library/papers/21946118 | PubMed |
| 19 | 33398531 | Brain stem gliomas and current landscape. | J Neurooncol | 2021 | https://conductscience.org/library/papers/33398531 | PubMed |
| 20 | 37358632 | A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas. | Neurosurg Rev | 2023 | https://conductscience.org/library/papers/37358632 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42043033 | Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42043033 | PubMed |
| 41540212 | Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma. | Commun Biol | 2026 | https://conductscience.org/library/papers/41540212 | PubMed |
| 40678065 | Spatial transcriptomic analysis of 4NQO-induced tongue cancer revealed cellular lineage diversity and evolutionary trajectory. | Front Oncol | 2025 | https://conductscience.org/library/papers/40678065 | PubMed |
| 40663259 | Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling. | Clin Exp Metastasis | 2025 | https://conductscience.org/library/papers/40663259 | PubMed |
| 39991094 | Big data for neuroscience in the context of predictive, preventive, and personalized medicine. | EPMA J | 2025 | https://conductscience.org/library/papers/39991094 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38201655
GET https://conductscience.org/api/papers/v1/38201655/references?page=2